The UK Multiple Sclerosis Register (UKMSR) was pleased to have had seven abstracts and six presentations accepted based on UK MS Register Data at European Committee Treatment and Research in Multiple Sclerosis (ECTRIMS) 2022 in Amsterdam last month. ECTRIMS is held once a year and is attended by over 7000 Academics, Researchers and Clinicians in…
The UK Multiple Sclerosis (MS) Register is not only celebrating a decade of vital data collection and research, it has also secured another £2 million of funding. The UK MS Register, based in Population Data Science in Swansea University Medical School is a world-leading research project in MS that uses real world data as part…
The MS Society has announced £100,000 funding for projects to use make use of MS Register Data to aim to increase understanding of MS risk factors. It is hoped the Data Discovery Awards will move research towards a more integrated approach to assessing someone’s risk of developing MS and ultimately inform new prevention strategies. The…
Dates: 5-6th July 2022 Location: Swansea Bay Campus Cost: The event, accommodation and food are free, however, there is a £50 administration fee More and more, research requires skills in analysing large data sets. Exciting discoveries have been made using electronic health care data but working with big data can be challenging. To get the best…
Research increasingly requires skills in analysing large data sets. Exciting discoveries have been made using electronic health care data but working with big data can be challenging. To get the best out of data you need to make sure you are using the latest and greatest tools and techniques in data analysis and manipulation. The…
New research finds that quitting smoking may cause slowing of Multiple Sclerosis (MS) disease progression.
Initial findings from a UK community-based COVID-19 study show that people with MS have no higher risk of contracting COVID-19 than the general population, during the early phase of the pandemic when strict precautions were taken.
A new research project born out of the current COVID-19 pandemic will track the moods of people with Multiple Sclerosis (MS) over time to monitor its effect on accelerating the progression of the disease.
Over 4100 people have responded to the MS Register initial (baseline) survey, 2000 of these people have gone on to answer a follow up survey. Two hundred people who have told us that they have a confirmed (by lab test or been told by a health care professional) or suspected case of coronavirus.
The UK MS Register team have put out a first – ‘baseline’ questionnaire on Coronavirus (COVID-19) and MS to collect data on how coronavirus is affecting People with MS (PwMS), and to learn if people on Disease Modifying Treatments (DMT) are really more susceptible, what advice should be given and to drive future recommendations.
